C²MV : Cardiovascular and Metabolic Complications in Patients Living with Human Immunodeficiency Virus

The main aim of our C2M2 GRC is to gain a better understanding of the cardiovascular and metabolic complications of people living with the human immunodeficiency virus (PLHIV). The results of this GRC's research will help improve cardiovascular and metabolic management in primary and secondary prevention of PLWHA, thereby helping to reduce the risk of cardiovascular events, particularly atherosclerotic ones (coronary artery disease, peripheral vascular disease), and better manage modifiable vascular risk factors (smoking, arterial hypertension, dyslipidemia and diabetes). We are a clinical research network including the Infectious and Tropical Diseases, Cardiology and Endocrinology clinical departments of the Eastern Paris Hospitals, as well as basic research structures in public health and biology at the Sorbonne University Faculty of Medicine.